| Akriti Sinha, MD | |
|
4601 Ironbound Rd, Williamsburg, VA 23188-2648 | |
| (757) 253-5161 | |
| (757) 253-5065 |
| Full Name | Akriti Sinha |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 4601 Ironbound Rd, Williamsburg, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093235434 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 0101270713 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Akriti Sinha, MD 4601 Ironbound Rd, Williamsburg, VA 23188-2648 Ph: (757) 253-4309 | Akriti Sinha, MD 4601 Ironbound Rd, Williamsburg, VA 23188-2648 Ph: (757) 253-5161 |
News Archive
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests. Currently, seasonal flu vaccines are designed to induce high levels of protective antibodies against hemagglutinin (HA), a protein found on the surface of the influenza virus that enables the virus to enter a human cell and initiate infection.
A 49-year-old male with a history of COVID-19 presents with tinnitus.
The results of a new study revealed that treatment for women with HER2-positive breast cancer – an aggressive form of the disease which is diagnosed in 10,000 British women each year – slowed the progression of tumors by 40 per cent compared with conventional drugs. Tests on 137 women showed that the new therapy – called T-DM1 – which combines the drug Herceptin with an antibody drug, instead of with standard chemotherapy, appeared to stop the cancer "in its tracks".
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, announced the publication of two separate peer-reviewed articles describing preclinical data demonstrating that treatment with ACE-041, an inhibitor of signaling through the activin receptor-like kinase 1 receptor, slows tumor growth and progression by inhibiting angiogenesis.
› Verified 9 days ago
Dr. Syed Zafar Ahsan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1657 Merrimac Trl, Williamsburg, VA 23185 Phone: 757-220-3200 Fax: 757-253-4013 | |
Dr. Margaret Hale Vincent, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1657 Merrimac Trl, Williamsburg, VA 23185 Phone: 757-220-3200 | |
Shawke A Soueidan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 120 Kings Way, Suite 2700, Williamsburg, VA 23185 Phone: 757-221-0110 Fax: 757-221-0851 | |
Dr. Chan Nguyen, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4601 Ironbound Rd, Williamsburg, VA 23188 Phone: 757-253-5347 Fax: 757-253-5319 | |
Dr. Avtar S Dhillon, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 5483 Mooretown Road, Williamsburg, VA 23188 Phone: 757-941-6400 Fax: 757-941-6419 | |
Paul Reilly, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1115 Old Colony Ln, Williamsburg, VA 23185 Phone: 757-253-0691 Fax: 757-220-9571 |